Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenue
Total revenue	$ 263,137	$ 85,518	$ 1,207,712	$ 666,619
Revenue from Contract with Customer, Product and Service [Extensible Enumeration]	Grant Revenue [Member]	Grant Revenue [Member]	Grant Revenue [Member]	Grant Revenue [Member]
Operating Expenses [Abstract]
Research and Development Expense	$ 6,822,198	$ 3,662,130	$ 14,769,253	$ 8,197,851
General and Administrative Expense	3,642,637	2,900,006	8,030,773	6,347,395
Total operating expenses	10,464,835	6,562,136	22,800,026	14,545,246
Loss from operations	(10,201,698)	(6,476,618)	(21,592,314)	(13,878,627)
Changes in fair value of warrant liabilities	2,216,973	(357,516)	7,685,192	(274,930)
Interest expense	(93,119)	(75,320)	(169,490)	(167,705)
Interest income	374,557	28,568	872,450	86,556
Other income	367,832		842,962
Total other income (expense)	2,866,243	(404,268)	9,231,114	(356,079)
Loss before income taxes	(7,335,455)	(6,880,886)	(12,361,200)	(14,234,706)
Net loss	(7,335,455)	(6,880,886)	(12,361,200)	(14,234,706)
Other comprehensive loss:
Unrealized gain (loss), change in fair value of available-for-sale securities, net of tax	12,463		(43,598)
Foreign currency translation	19,632		(14,175)
Total comprehensive loss	$ (7,303,360)	$ (6,880,886)	$ (12,418,973)	$ (14,234,706)
Loss per common share attributable to the Company's shareholders
Basic loss per common share	$ (0.79)	$ (1.36)	$ (1.34)	$ (2.82)
Diluted loss per common share	$ (0.79)	$ (1.36)	$ (1.34)	$ (2.82)
Weighted-average common shares outstanding - basic	9,255,025	5,042,126	9,248,503	5,040,741
Weighted-average common shares outstanding - diluted	9,255,025	5,042,126	9,248,503	5,040,741